Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119361302 | 11936130 | 2 | F | 201511 | 20160215 | 20160121 | 20160726 | PER | US-AMGEN-USASL2015136597 | AMGEN | 62.00 | YR | A | F | Y | 0.00000 | 20160726 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119361302 | 11936130 | 1 | PS | KYPROLIS | CARFILZOMIB | 1 | Unknown | 27 MG/M2, QD | U | 202714 | 27 | MG/M**2 | INTRAVENOUS INFUSION | QD | |||||
| 119361302 | 11936130 | 2 | SS | KYPROLIS | CARFILZOMIB | 1 | Unknown | 56 MG/M2, UNK | U | 202714 | 56 | MG/M**2 | INTRAVENOUS INFUSION | ||||||
| 119361302 | 11936130 | 3 | SS | NEUPOGEN | FILGRASTIM | 1 | Unknown | UNK | U | 0 | UNKNOWN FORMULATION | ||||||||
| 119361302 | 11936130 | 4 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119361302 | 11936130 | 1 | Plasma cell myeloma |
| 119361302 | 11936130 | 3 | Acute myeloid leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119361302 | 11936130 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119361302 | 11936130 | Adverse drug reaction | |
| 119361302 | 11936130 | Blood calcium increased | |
| 119361302 | 11936130 | Blood creatinine increased | |
| 119361302 | 11936130 | Blood immunoglobulin A increased | |
| 119361302 | 11936130 | Drug ineffective | |
| 119361302 | 11936130 | Neutropenia | |
| 119361302 | 11936130 | Off label use | |
| 119361302 | 11936130 | Paraproteinaemia | |
| 119361302 | 11936130 | Renal disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119361302 | 11936130 | 1 | 20151116 | 0 | ||
| 119361302 | 11936130 | 2 | 20160126 | 0 |